Abstract
The average weight-losing pancreatic cancer patient undergoing palliative therapy is frequently overweight rather than underweight, and this can confound conventional measures used for risk stratification. The aim of this study was to evaluate if weight and body composition, specifically sarcopenia, assessed from diagnostic computed tomography (CT) scans, is of prognostic value in patients with pancreatic cancer. The nature and extent of tissue loss over subsequent months was also evaluated.
Original language | English |
---|---|
Pages (from-to) | 6973-6979 |
Number of pages | 7 |
Journal | Clinical Cancer Research |
Volume | 15 |
Issue number | 22 |
DOIs | |
Publication status | Published - 2009 |
Keywords
- Aged
- Body Composition
- Body Weight
- Female
- Humans
- Male
- Middle Aged
- Obesity
- Overweight
- Pancreatic Neoplasms
- Prognosis
- Risk
- Sarcopenia
- Tomography, X-Ray Computed
- Treatment Outcome